NCT00079053 2023-08-04
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Canadian Cancer Trials Group
Phase 1 Completed
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC